Biospatial

Biospatial, headquartered in Durham, North Carolina, is a leading healthcare analytics company specializing in the integration and analysis of Emergency Medical Services (EMS) data to enhance public health and safety. Established in 2016, the company has developed a robust platform that aggregates electronic Patient Care Reports (ePCRs) from a vast network of EMS providers across the United States. By combining these reports with other electronic healthcare data sources and employing proprietary artificial intelligence (AI) algorithms, Biospatial delivers actionable insights to a diverse clientele, including public sector agencies and commercial healthcare entities.

As of March 2022, Biospatial's platform had ingested and analyzed over 150 million ePCRs, collected from thousands of EMS agencies in more than 40 U.S. states. The company continues to expand its data network, processing over 100,000 new ePCRs daily. This extensive dataset enables Biospatial to compute and monitor over 150 EMS quality and performance measures, including the 21 National EMS Quality Alliance (NEMSQA) measures. These analytics support various applications such as biosurveillance, substance abuse and overdose trend analysis, automotive safety assessments, disaster response and recovery, and COVID-19 tracking for state and federal agencies.

Biospatial has established significant partnerships to enhance its service offerings and data quality. In March 2024, the company entered into a strategic partnership with NEMSQA to support the development of evidence-based quality measures for EMS and healthcare partners. This collaboration underscores Biospatial's commitment to advancing EMS data quality and providing stakeholders with data-driven insights to improve patient care and outcomes.

In January 2025, Biospatial was acquired by ImageTrend, a prominent provider of software solutions for emergency services and healthcare organizations. This acquisition aims to combine the strengths of both companies to transform healthcare and emergency services through powerful data insights. The integration is expected to enhance the capabilities of both platforms, offering clients improved tools for data analysis and decision-making.

Biospatial has attracted investment from several venture capital firms to support its growth and technological advancements. In March 2022, the company closed a $3.4 million Series A funding round led by Cofounders Capital, with participation from Front Porch Venture Partners, East Carolina Angels, Gratus Private Capital, and existing investors such as Bull City Venture Partners, IDEA Fund Partners, Alerion Ventures, and Wolfpack Investor Network. This funding has enabled Biospatial to expand its customer base and enhance its data analytics capabilities, further solidifying its position in the healthcare analytics sector.

Biospatial's core mission is to improve healthcare outcomes through data science. By leveraging its expansive data network and advanced AI-driven analytics, the company strives to provide timely, actionable information that empowers EMS agencies, healthcare providers, and public health organizations to make informed decisions. Through continuous innovation and strategic collaborations, Biospatial is dedicated to enhancing public health and safety across communities nationwide.